The Next Generation of Cerebral Palsy Treatment #
While conventional cerebral palsy treatment only focuses on managing symptoms, our innovative protocol is designed to help the body repair brain damage, regrow neurons, and improve quality of life. It uses non-invasive technology designed to activate the body’s neuron regrowth and repair broken connections in the neural network.
We have studied the safety and efficacy of our protocol for people with cerebral palsy, and have received COFEPRIS approval of our protocol for patients with cerebral palsy.
Non-invasive precision treatment is the future of cerebral palsy treatment #
At NeuroCytonix, we want to revolutionize cerebral palsy treatment.
Our protocol uses a combination of magnetic fields and low-energy radio waves, like the frequencies used in MRI machines. Each person receives a personalized version of the protocol with calculated radiofrequency doses delivered by our medical device, to injured areas of the brain. The protocol is performed one hour a day for 28 days in a row.
Learn about our innovative technology
Our CP Clinical Trial #
In 2019, the protocol for children with cerebral palsy was studied in a randomized, placebo-controlled clinical trial at our NeuroCytonix Mexico clinical research center. Half the children in the study received the protocol and half did not. To measure differences between the two groups, we used the Pediatric Evaluation of Disability Inventory (PEDI) which tests the functional ability of children ages six months to seven years old.
The clinical and imaging data provided evidence that participants who received the NeuroCytonix protocol showed improvements in their symptoms and quality of life as compared to those that received placebo.
The Mexican regulatory authority COFEPRIS, the Mexico equivalent to the U.S. FDA (Food and Drug Administration), acknowledged the results of this clinical trial and approved the cerebral palsy protocol.
Our clinical trial results included:
- PEDI scores measuring self-care, mobility, and social skills increased almost twice as much for children who received the protocol compared to those who didn’t.
- On average, the rate of score improvement was higher for the protocol group than the group who didn’t receive the protocol.
- Ashworth scores, which measure spasticity–or muscle stiffness that makes it harder to move–showed less spasticity after the protocol as compared to patients receiving placebo.
- In participants with moderate brain damage, we saw more improvement in the treated group compared to placebo. Children who received the protocol gained more independence in dressing, bathing, and peer play as measured by the Pediatric Quality of Life Inventory (PedsQL) a tool for measuring the overall well-being and quality of life in children and teenagers. Meals were easier and they were more able to use utensils.
- MRI images showed more new neural tracts after the protocol was administered compared to placebo treated patients. The images suggest the presence of many more functioning neurons, especially where the brain had been injured. These results speak to the protocol’s feasibility as a cerebral palsy treatment that may help heal the brain.
Post-Protocol Clinical Observations #
Our team of medical and scientific experts found that the protocol had no significant adverse effects for the children in the study. Both clinical and behavioral observations provided evidence for the protocol’s potential as a cerebral palsy treatment.
We are currently seeking FDA authorization for our clinical trial and working to publish the results. To learn more about our protocol’s potential as a new cerebral palsy treatment, read our case studies.
Enhancing Quality of Life #
Families of the children who received the protocol describe witnessing significant improvements in their daily lives. Parents reported that their children were more engaged with the family, with some reporting that they were also more loving to their pets. Some children have become more interested in learning words and copying their parents’ actions. After the protocol, children have shown more curiosity about the world and a stronger desire to learn.
If you or a loved one are interested in our CP protocol, please fill out the eligibility form.
NeuroCytonix Mexico Clinical Research Center #
Discover the future of medical research at our state-of-the-art clinical research center.
